Skip to content

BPH Global Registry

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, we have started a prospective, ongoing international registry for recording demographics and outcomes for patients undergoing surgical treatments for BPH.

null

Participation Requirements

  • Sex:

    MALE

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* Primary diagnosis of BPH with LUTS with prescribed medical treatment or surgical intervention

Exclusion Criteria:

* Non-symptomatic BPH
* No treatment prescribed for BPH

Study Location

McGill University Health Centre
McGill University Health Centre
Montréal, Quebec
Canada

Contact Study Team

Princess Margaret Cancer Centre
Princess Margaret Cancer Centre
Toronto, Ontario
Canada

Contact Study Team

Primary Contact

Dean Elterman, MD

[email protected]
McGill University Health Centre
McGill University Health Centre
Montreal, Quebec
Canada

Contact Study Team

Primary Contact

Mélanie Aubé-Peterkin, MD

[email protected]
Toronto Western Hospital, University Health Network
Toronto Western Hospital, University Health Network
Toronto, Ontario
Canada

Contact Study Team

Primary Contact

Iris Chan

[email protected]
Study Sponsored By
Société Internationale d'Urologie
Participants Required
More Information
Study ID: NCT05543200